100PercentFedUp.com On Monday, Pfizer and BioNTech announced that they have submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization of their unpopular bivalent COVID-19 vaccine for children under 5 years old.
Pfizer has already had its original vaccine approved for children aged 6 months to four years old. Children have been instructed to receive three very small doses of the shot for their primary vaccination. Now, despite COVID posing a very minor risk to children under 5, Pfizer wants them to start receiving their new bivalent shot as part of their initial round of vaccines.
Pfizer has explained that children would receive two doses of the original vaccine, followed by a third shot of the bivalent vaccine…
